Sorbitol-penetration enhancer containing vesicles loaded with baicalin for the protection and regeneration of skin injured by oxidative stress and UV radiation.


Journal

International journal of pharmaceutics
ISSN: 1873-3476
Titre abrégé: Int J Pharm
Pays: Netherlands
ID NLM: 7804127

Informations de publication

Date de publication:
30 Jan 2019
Historique:
received: 17 09 2018
revised: 19 11 2018
accepted: 19 11 2018
pubmed: 24 11 2018
medline: 11 4 2019
entrez: 24 11 2018
Statut: ppublish

Résumé

Aiming at improving the protective effects of baicalin on the skin, new highly-biocompatible penetration enhancer containing vesicles (PEVs) were developed by modifying the base formulation of transfersomes with sorbitol, thus obtaining sorbitol-PEVs. An extensive evaluation of the physico-chemical features of both transfersomes and sorbitol-PEVs was carried out. Transfersomes were mainly close-packed, multi-compartment vesicles, while sorbitol-PEVs appeared mostly as single, spherical, unilamellar vesicles. All the vesicles were small in size (∼128 nm) and negatively charged (∼-67 mV), without significant differences between the formulations. The in vitro delivery of baicalin to intact skin showed an improved ability of sorbitol-PEVs to favour the deposition of the flavonoid into the whole skin. In addition, the vesicular formulations protected keratinocytes and fibroblasts from oxidative stress and UV radiation, and promoted cell proliferation and migration, which favoured the closure of skin wound. Cell uptake was promoted as well, especially when sorbitol-PEVs were used.

Identifiants

pubmed: 30468844
pii: S0378-5173(18)30877-9
doi: 10.1016/j.ijpharm.2018.11.053
pii:
doi:

Substances chimiques

Excipients 0
Flavonoids 0
baicalin 347Q89U4M5
Sorbitol 506T60A25R

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

175-183

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Maria Letizia Manca (ML)

Dept. of Scienze della Vita e dell'Ambiente, University of Cagliari, Via Ospedale 72, 09124 Cagliari, Italy.

Silvia Mir-Palomo (S)

Dept. of Pharmacy and Pharmaceutical Technology and Parasitology, University of Valencia, Burjassot, Vicente Andrés Estellés s/n, Valencia 46100, Spain.

Carla Caddeo (C)

Dept. of Scienze della Vita e dell'Ambiente, University of Cagliari, Via Ospedale 72, 09124 Cagliari, Italy. Electronic address: caddeoc@unica.it.

Amparo Nacher (A)

Dept. of Pharmacy and Pharmaceutical Technology and Parasitology, University of Valencia, Burjassot, Vicente Andrés Estellés s/n, Valencia 46100, Spain; Institute of Molecular Recognition and Technological Development, Inter-University Institute from Polytechnic University of Valencia and University of Valencia, Spain.

Octavio Díez-Sales (O)

Dept. of Pharmacy and Pharmaceutical Technology and Parasitology, University of Valencia, Burjassot, Vicente Andrés Estellés s/n, Valencia 46100, Spain; Institute of Molecular Recognition and Technological Development, Inter-University Institute from Polytechnic University of Valencia and University of Valencia, Spain.

Josè Esteban Peris (JE)

Dept. of Pharmacy and Pharmaceutical Technology and Parasitology, University of Valencia, Burjassot, Vicente Andrés Estellés s/n, Valencia 46100, Spain.

Josè Luis Pedraz (JL)

NanoBioCel Group, University of Basque Country, Paseo de la Universidad 7, 01006 Vitoria, Spain; Networking Research Centre of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Spain.

Anna Maria Fadda (AM)

Dept. of Scienze della Vita e dell'Ambiente, University of Cagliari, Via Ospedale 72, 09124 Cagliari, Italy.

Maria Manconi (M)

Dept. of Scienze della Vita e dell'Ambiente, University of Cagliari, Via Ospedale 72, 09124 Cagliari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH